Engineering autoreactive T and B cell responses toward active immunotherapy for inflammatory diseases [Applied Biological Sciences]
Antiinflammatory therapeutics are commonly used to combat a vast array of chronic inflammatory and autoimmune diseases, including rheumatoid arthritis, inflammatory bowel disease, psoriasis, and Crohn’s disease (1). These chronic inflammatory diseases affect ∼5 to 7% of the population, creating a significant socioeconomic burden and impact on patients’ quality of life...
Source: Proceedings of the National Academy of Sciences - Category: Science Authors: Jason Y. H. Chang, Darrell J. Irvine Tags: Applied Biological Sciences, Commentaries Commentary Source Type: research
More News: Academies | Arthritis | Autoimmune Disease | Immunotherapy | Inflammatory Bowel Disease | Psoriasis | Rheumatoid Arthritis | Rheumatology | Science